EAAT2 Recombinant Antibody
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bsm-61066r |
| Product Name | EAAT2 Recombinant Antibody |
| Applications |
WB
|
| Reactivity | Mouse, Rat |
| Predicted Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | A synthesized peptide derived from human EAAT2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 6506 |
| Swiss Prot | P43004 |
| Subcellular location | Cell membrane |
| Synonyms | DEE41; EAAT2; EIEE41; GLT-1; GLT1; HBGT; 1700091C19Rik; 2900019G14Rik; MGLT1; Glt; EAA2_HUMAN; SLC1A2; Glutamate/aspartate transporter II; Sodium-dependent glutamate/aspartate transporter 2; Solute carrier family 1 member 2; EAA2_MOUSE; EAA2_RAT; Sodium-dependent glutamate/aspartate transporter 2 (GLUT-R); solute carrier family 1 (glial high affinity glutamate transporter), member 2; glutamate transporter-1; Excitatory amino acid transporter 2; human brain glutamate transporter |
| Background | This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Mutations in and decreased expression of this protein are associated with amyotrophic lateral sclerosis. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Sep 2010] |
| Application Dilution | |
| WB | 1:500-2000 |